Please login to the form below

Not currently logged in
Email:
Password:

Amarin

This page shows the latest Amarin news and features for those working in and with pharma, biotech and healthcare.

Amarin hits jackpot with astonishing heart benefits from fish oil product

Amarin hits jackpot with astonishing heart benefits from fish oil product

Amarin CEO John Thero. “We are delighted with these topline study results, ”said John Thero, president and CEO of Amarin. ... of LDL-C control with standard of care statin therapy in studied patients, ”added Craig Granowitz, MD, PhD, senior vice

Latest news

  • Amarin sues FDA over off-label policy Amarin sues FDA over off-label policy

    Amarin sues FDA over off-label policy. Claims block on discussing off-label uses conflicts freedom of speech. ... Amarin is in the process of carrying out a cardiovascular outcomes study called REDUCE-IT to try to support its position, with results due

  • Teva launches first generic of GSK's Lovaza in US Teva launches first generic of GSK's Lovaza in US

    Aside from GSK, the launch of a lower-priced Lovaza generic in the US also impacts Amarin Pharmaceuticals' Vascepa (icosapent ethyl), another fish oil-based therapy that is already on the

  • Amarin slides as FDA panel votes against fish oil therapy Amarin slides as FDA panel votes against fish oil therapy

    Amarin slides as FDA panel votes against fish oil therapy. Advisory committee wants more data on Vascepa. ... Meanwhile, the cost of running REDUCE-IT is also a drain on Amarin's finances, with the bill for 2013 expected to come in at somewhere between

  • Senior changes for Forest and Amarin

    Olanoff, effective December 31, while Amarin Corporation has announced that Joseph S Zakrzewski, an experienced biotech executive, has been appointed as its chief executive officer, effective immediately. ... Amarin. Prior to joining Amarin, Thero was

  • Prior to joining Pharmacopeia, Liebler served as senior vice-president of strategic Planning at Questcor and held executive-level positions with Enzon, Elan, Amarin and Athena Neurosciences.

More from news
Approximately 3 fully matching, plus 5 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Teva's Mark Salyer joins Amarin Teva's Mark Salyer joins Amarin

    Teva's Mark Salyer joins Amarin. Takes up newly-created chief commercial officer role. ... Amarin has appointed Mark Salyer to the newly-created position of chief commercial officer.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics